Characterisation of APS-1 Experimental Models Is Crucial for Development of Novel Therapies

Sarah Almaghrabi1, Thomas Lovewell1, Mimoun Azzouz2

  • 1Department of Infection, Immunity and Cardiovascular Disease, Sheffield, UK.